Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 14/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9640505 | 1.00 | ALOX5 (0.50) | ALOX5PTGS2HTR2APPARAGLS2 | |
| SCHEMBL19304408 | 1.00 | ALOX5 (0.50) | ALOX5PTGS2HTR2APPARAGLS2 | |
| SCHEMBL9444539 | 1.00 | ALOX5 (0.50) | ALOX5PTGS2HTR2APPARAGLS2 | |
| SCHEMBL9298398 | 0.92 | ALOX5 (0.42) | ALOX5PTGS2HTR2APPARA | |
| SCHEMBL8516248 | 0.84 | HMGCR (0.47) | ALOX5PTGS2HTR2A | |
| SCHEMBL23317299 | 0.84 | ALOX5 (0.38) | ALOX5PTGS2HTR2APPARA | |
| SCHEMBL9642087 | 0.84 | TSHR (0.39) | ALOX5PTGS2HTR2A | |
| SCHEMBL721811 | 0.84 | ALOX5 (0.38) | ALOX5PTGS2HTR2A | |
| SCHEMBL2745239 | 0.82 | LIPG (0.45) | ALOX5PTGS2HTR2A | |
| SCHEMBL2745125 | 0.82 | LIPG (0.45) | ALOX5PTGS2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9150414-B2 | Nanocomposite and dispersion comprising the same | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20120292577-A1 | REGIOREGULAR POLYTHIOPHENE AND PROCESS FOR PRODUCTION THEREOF | KURARAY CO., LTD. (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20120292577-A1 | REGIOREGULAR POLYTHIOPHENE AND PROCESS FOR PRODUCTION THEREOF | KURARAY CO., LTD. (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20120053288-A1 | NANOCOMPOSITE AND DISPERSION COMPRISING THE SAME | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120292577-A1 | REGIOREGULAR POLYTHIOPHENE AND PROCESS FOR PRODUCTION THEREOF | NTRK1, ETV1, EPB41 | ALOX5 1589/4885PTGS2 1322/4885HTR2A 4542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.